Want to see ROIV full AI Analyst Report?
Roivant Sciences (ROIV) Stock Forecast & Price Target
ROIV Analyst Ratings
ROIV Stock 12 Month Forecast
Average Price Target
$48.80▲(32.21% Upside)Detailed List of Analyst Forecasts
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
| Samantha Semenkow | Citi | $46→$56 | buy | 51.72%Upside | Reiterated | 10/29/26 | ||
| Douglas Tsao | H.C. Wainwright | $47 | buy | 27.34%Upside | Reiterated | 10/21/26 | ||
| Yaron Werber | TD Cowen | $55→$62 | buy | 67.98%Upside | Reiterated | 10/21/26 | ||
| Chi Meng Fong | Bank of America Securities | $41 | hold | 11.08%Upside | Reiterated | 10/21/26 | ||
| Andy Chen | Wolfe Research | ― | hold | ― | Downgraded | 10/12/26 | ||
| Eve Burstein | Bernstein | $41 | buy | 11.08%Upside | Reiterated | 09/25/26 | ||
| Alex Thompson CFA | Stifel Nicolaus | $51 | buy | 38.17%Upside | Initiated | 09/17/26 | ||
| Brian Cheng | J.P. Morgan | ― | buy | ― | Reiterated | 09/17/26 | ||
| Leerink Partners | $42→$52 | buy | 40.88%Upside | Reiterated | 09/16/26 | |||
| Dennis Ding | Jefferies | $42→$52 | buy | 40.88%Upside | Reiterated | 09/08/26 | ||
| Yatin Suneja | Guggenheim | $42→$46 | buy | 24.63%Upside | Reiterated | 09/08/26 | ||
| Yasmeen Rahimi | Piper Sandler | $40 | buy | 8.37%Upside | Reiterated | 08/28/26 | ||
| Corinne Johnson | Goldman Sachs | $38→$41 | buy | 11.08%Upside | Reiterated | 04/15/26 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| Samantha Semenkow | 10/29/26 | $46→$56 | buy | 51.72%Upside | Reiterated | Citi | ||
| Douglas Tsao | 10/21/26 | $47 | buy | 27.34%Upside | Reiterated | H.C. Wainwright | ||
| Yaron Werber | 10/21/26 | $55→$62 | buy | 67.98%Upside | Reiterated | TD Cowen | ||
| Chi Meng Fong | 10/21/26 | $41 | hold | 11.08%Upside | Reiterated | Bank of America Securities | ||
| Andy Chen | 10/12/26 | ― | hold | ― | Downgraded | Wolfe Research | ||
| Eve Burstein | 09/25/26 | $41 | buy | 11.08%Upside | Reiterated | Bernstein | ||
| Alex Thompson CFA | 09/17/26 | $51 | buy | 38.17%Upside | Initiated | Stifel Nicolaus | ||
| Brian Cheng | 09/17/26 | ― | buy | ― | Reiterated | J.P. Morgan | ||
| 09/16/26 | $42→$52 | buy | 40.88%Upside | Reiterated | Leerink Partners | |||
| Dennis Ding | 09/08/26 | $42→$52 | buy | 40.88%Upside | Reiterated | Jefferies | ||
| Yatin Suneja | 09/08/26 | $42→$46 | buy | 24.63%Upside | Reiterated | Guggenheim | ||
| Yasmeen Rahimi | 08/28/26 | $40 | buy | 8.37%Upside | Reiterated | Piper Sandler | ||
| Corinne Johnson | 04/15/26 | $38→$41 | buy | 11.08%Upside | Reiterated | Goldman Sachs |
Best Analysts Covering Roivant Sciences
Copying Brian Cheng's trades and holding each position for 3 Months would result in 81.82% of your transactions generating a profit, with an average return of +19.28% per trade.
Copying David Risinger's trades and holding each position for 1 Year would result in 91.43% of your transactions generating a profit, with an average return of +75.27% per trade.
Copying David Risinger's trades and holding each position for 2 Years would result in 97.14% of your transactions generating a profit, with an average return of +142.28% per trade.
ROIV Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 2 |
| Buy | 11 | 8 | 12 | 20 | 21 |
| Hold | 2 | 3 | 3 | 4 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 13 | 11 | 15 | 24 | 29 |
In the current month, ROIV has received 23 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. ROIV average Analyst price target in the past 3 months is 48.80.
ROIV Financial Forecast
ROIV Earnings Forecast
Next quarter’s earnings estimate for ROIV is -$0.37 with a range of -$0.59 to -$0.19. The previous quarter’s EPS was -$0.34. ROIV beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ROIV has Performed in-line its overall industry.
ROIV Sales Forecast
Next quarter’s sales forecast for ROIV is $4.14M with a range of $1.44M to $8.00M. The previous quarter’s sales results were $1.44M. ROIV beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ROIV has Performed in-line its overall industry.